Publications
evaluation
The global vaccine action plan monitoring and evaluation/ accountability framework: Perspective
Vaccine Volume 38, Issue 33, pp. 5384-5386
MMGH Author(s)
strategy
Vaccine implementation factors affecting maternal tetanus immunization in low- and middle-income countries: Results of the Maternal Immunization and Antenatal Care Situational Analysis (MIACSA) project
Vaccine Volume 38, Issue 33, pp. 5268-5277
MMGH Author(s)
strategy
Maternal immunization country readiness: a checklist approach
Human Vaccines & Immunotherapeutics
MMGH Author(s)
evaluation
Global Vaccine Action Plan Lessons Learned III: Monitoring and evaluation/accountability framework
Vaccine Volume 38, Issue 33, pp. 5379-5383
MMGH Author(s)
development
The potential impact of human visceral leishmaniasis vaccines on population incidence
PLOS
MMGH Author(s)
implementation
Use of Tetanus-Diphtheria (Td) Vaccine in Children 4-7 Years of Age: World Health Organization Consultation of Experts
Vaccine Volume 38, Issue 21, pp. 3800-3807
MMGH Author(s)
evaluation
Global Vaccine Action Plan Lessons Learned II: Stakeholder Perspectives
Vaccine Volume 38, Issue 33, pp. 5372-5378
MMGH Author(s)
implementation
Global market study: Pneumococcal conjugate (PCV) and polysaccharide (PPV) vaccines
WHO publication
MMGH Author(s)
development
Does Respiratory Syncytial Virus Lower Respiratory Illness in Early Life Cause Recurrent Wheeze of Early Childhood and Asthma? Critical Review of the Evidence and Guidance for Future Studies From a World Health Organization-sponsored Meeting
Vaccine Volume 38, Issue 11, pp. 2435-2448
MMGH Author(s)